University of British Columbia, St. Paul's Hospital
Welcome,         Profile    Billing    Logout  
 10 Trials 
13 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Cheung, Anson
TIARA-I, NCT02276547: Early Feasibility Study of the Neovasc Tiara™ Mitral Valve System

Active, not recruiting
N/A
27
Europe, Canada, US
Mitral valve replacement, TIARA Mitral Transcatheter Heart Valve, TIARA Transapical Delivery System
Neovasc Inc.
Mitral Valve Regurgitation
01/20
02/25
NCT03616678: VenTouch OUS Feasibility Study

Recruiting
N/A
15
Europe, Canada, RoW
VenTouch System
Mardil Medical
Functional Mitral Regurgitation
05/21
12/23
Viklicky, Ondrej
INHIBIT, NCT04302805: rATG Versus rATG Combined With Intravenous Immunoglobulin (IVIG) Induction Immunosuppression in HLA Incompatible Transplantation

Completed
3
17
RoW
Privigen, IVIG, Kiovig, Thymoglobulin, rATG, Plasma Exchange, PE
Institute for Clinical and Experimental Medicine
Kidney Transplantation
04/24
06/24
FALCON, NCT03918447 / 2018-004651-20: A Trial of Bardoxolone Methyl in Patients With ADPKD -

Terminated
3
667
Europe, Japan, US, RoW
Bardoxolone methyl oral capsule, RTA 402, Placebo oral capsule
Reata, a wholly owned subsidiary of Biogen, Reata Pharmaceuticals, Inc., REATA PHARMACEUTICALS, INC
Autosomal Dominant Polycystic Kidney, ADPKD
08/23
08/23
IMAGINE, NCT03744910 / 2018-003682-34: Clazakizumab for the Treatment of Chronic Active Antibody Mediated Rejection in Kidney Transplant Recipients

Terminated
3
194
Europe, Canada, US, RoW
Clazakizumab, Physiologic saline solution
CSL Behring, ICON Clinical Research
Antibody-mediated Rejection
04/24
04/24
NCT06274489: A Study to Evaluate Setanaxib in Patients With Alport Syndrome

Active, not recruiting
1/2
18
Europe, RoW
Setanaxib, Placebo
Calliditas Therapeutics AB
Alport Syndrome
01/25
01/25
MoliDon, NCT06171438: Molecular Markers of Acute Kidney Injury in Elderly Deceased Donors

Completed
N/A
200
RoW
Urine Biomarkers, Gene expression profiling of donor kidneys by microarray, Gene expression profiling of recipient kidneys by microarray
Institute for Clinical and Experimental Medicine
Kidney Transplantation, Acute Kidney Injury
12/22
10/23
TASMANIA, NCT04832841: IgG Antibodies After SARS-CoV-2 mRNA Vaccine in Kidney Transplantation

Completed
N/A
753
RoW
anti-spike SARS-CoV-2 IgG
Institute for Clinical and Experimental Medicine
Kidney Transplantation
09/21
03/22
DEFILE, NCT06476717: Donor-derived Cell-free DNA in Kidney Transplant Recipients

Active, not recruiting
N/A
143
RoW
Biopsy, Blood Biomarkers - cfDNA, dd-cfDNA, Antirejection therapy
Institute for Clinical and Experimental Medicine, Natera, Inc.
Kidney Transplantation, Acute Rejection of Renal Transplant
05/24
12/24
NCT05483725: Immunological Safety and Effectiveness of the First Booster Dose of mRNA Vaccines Against COVID-19 in Kidney Transplant Recipients.

Active, not recruiting
N/A
108
RoW
Booster dose of mRNA vaccine
Institute for Clinical and Experimental Medicine
Kidney Diseases, Kidney Transplant; Complications, COVID-19, Vaccine Adverse Reaction, Rejection Acute Renal, Rejection Chronic Renal
12/24
12/24
NCT01299168: Diagnostic and Therapeutic Applications in Microarrays in Organ Transplantation

Recruiting
N/A
500
Europe, Canada, US, RoW
University of Alberta
Validation Study of Molecular Diagnostic System, Development of Reporting System for Molecular Diagnosis, Incorporate Molecular Diagnosis Into Diagnostic Standards
12/25
06/26
NCT04239703: Trifecta-Kidney cfDNA-MMDx Study

Recruiting
N/A
300
Europe, Canada, US, RoW
MMDx, Prospera, transplant patient blood sample, HLA antibody
University of Alberta, Natera, Inc., One Lambda
Kidney Transplant Rejection
12/25
12/26
Mok, Catherin
NCT03616678: VenTouch OUS Feasibility Study

Recruiting
N/A
15
Europe, Canada, RoW
VenTouch System
Mardil Medical
Functional Mitral Regurgitation
05/21
12/23

Download Options